These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38738254)

  • 1. Relationship of various COVID-19 antibody titer with individual characteristics and prediction of future epidemic trend in Xiamen City, China.
    Xu L; Abudunaibi B; Zeng Z; Zhao Y; Wang Y; Guo X; Zhang Y; Li T; Lu W; Tian W; Guo Z; Su C; Chen T
    J Thorac Dis; 2024 Apr; 16(4):2404-2420. PubMed ID: 38738254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Shedding of SARS-CoV-2 Virus in COVID-19 Patients and Neutralizing Antibody Level].
    Ayhancı T; Toptan H; Özer YE; Uzar S; Enül H; Adıay C; Sarac F; Dheir H; Köroğlu M; Hasöksüz M; Altındiş M
    Mikrobiyol Bul; 2022 Jul; 56(3):416-431. PubMed ID: 35960235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT - IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy).
    Isgrò MA; Trillò G; Russo L; Tornesello AL; Buonaguro L; Tornesello ML; Miscio L; Normanno N; Bianchi AAM; Buonaguro FM; Cavalcanti E;
    Infect Agent Cancer; 2022 Jul; 17(1):40. PubMed ID: 35902961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function is more reliable than quantity to follow up the humoral response to the Receptor Binding Domain of SARS- CoV-2 Spike protein after natural infection or COVID-19 vaccination.
    Sariol CA; Pantoja P; Serrano-Collazo C; Rosa-Arocho T; Armina A; Cruz L; Stone ET; Arana T; Climent C; Latoni G; Atehortua D; Pabon-Carrero C; Pinto AK; Brien JD; Espino AM
    medRxiv; 2021 Aug; ():. PubMed ID: 34100029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survey of spike-specific immunoglobulin G antibodies at approximately 3 months and 9 months after vaccination against coronavirus disease 2019 (severe acute respiratory syndrome coronavirus-2 [SARS-CoV-2]) in health care workers].
    Miyajima E; Imaizumi H; Oshida S; Igarashi K; Yoshida M; Yanase N
    Sangyo Eiseigaku Zasshi; 2023 Jan; 65(1):18-27. PubMed ID: 35314567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time dependent decline of neutralizing antibody titers in COVID-19 patients from Pune, India and evidence of reinfection.
    Doke P; Gothankar JS; Doke PP; Kulkarni MM; Khalate KK; Shrivastava S; Patil JR; Arankalle VA
    Microbes Infect; 2022 Jun; 24(4):104979. PubMed ID: 35452812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological study using IgM and IgG antibody titers against SARS-CoV-2 in The University of Tokyo, Japan (UT-CATS).
    Mitani A; Hamada K; Yoshikawa N; Morita Y; Horie T; Inoue Y; Saito M; Ishii T; Sunohara M; Takahashi R; Emoto N; Nishimoto N; Murano Y; Okazaki S; Tateishi S; Yao A; Shimura T; Kurano M; Yatomi Y; Yanagimoto S
    J Infect Chemother; 2021 Sep; 27(9):1342-1349. PubMed ID: 34158239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration and heritability of immunoglobulin G and natural antibody immunoglobulin M in dairy and beef colostrum along with serum total protein in their calves.
    Altvater-Hughes TE; Hodgins DC; Wagter-Lesperance L; Beard SC; Cartwright SL; Mallard BA
    J Anim Sci; 2022 Feb; 100(2):. PubMed ID: 35022742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan.
    Huang YF; Hsu FC; Wu JJ; Lin YL; Liu MT; Yang CH; Kuo HS; Chen YJ; Cheng CY; Lin HH; Liao CC; Chang CS; Liang JJ; Cheng WY; Huang JC; Chen CP; Cheng SH; Lin YC; Yang SH; Chou YJ
    J Microbiol Immunol Infect; 2023 Jun; 56(3):506-515. PubMed ID: 36967265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term SARS-CoV-2 neutralizing antibody level prediction using multimodal deep learning: A prospective cohort study on longitudinal data in Wuhan, China.
    Fang C; Yan W; Chen Y; Dou Z; Liu T; Luo F; Chen W; Li X; Chen Y; Wu W; Yuan Z; Niu Y; Wang P; Zhu W; Luo X; Chen T; Bai X; Wang X; Ning Q
    J Med Virol; 2023 Aug; 95(8):e29036. PubMed ID: 37621210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waning of Humoral Immunity and the Influencing Factors after BNT162b2 Vaccination: A Cohort Study with a Latent Growth Curve Model in Fukushima.
    Kobashi Y; Takebayashi Y; Yoshida M; Kawamura T; Shimazu Y; Kaneko Y; Nishikawa Y; Nakayama A; Takita M; Zhao T; Yamamoto C; Ito N; Tsubokura M
    Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of anti-spike IgG antibody after a third BNT162b2 COVID-19 vaccination in Japanese health care workers.
    Ikezaki H; Nomura H; Shimono N
    Heliyon; 2022 Dec; 8(12):e12125. PubMed ID: 36506407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China.
    Wu F; Liu M; Wang A; Lu L; Wang Q; Gu C; Chen J; Wu Y; Xia S; Ling Y; Zhang Y; Xun J; Zhang R; Xie Y; Jiang S; Zhu T; Lu H; Wen Y; Huang J
    JAMA Intern Med; 2020 Oct; 180(10):1356-1362. PubMed ID: 32808970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
    Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
    Front Immunol; 2022; 13():827306. PubMed ID: 35173736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal and Systemic Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Determined by Severity of Primary Infection.
    Sajadi MM; Myers A; Logue J; Saadat S; Shokatpour N; Quinn J; Newman M; Deming M; Rikhtegaran Tehrani Z; Magder LS; Karimi M; Abbasi A; Shlyak M; Baracco L; Frieman MB; Crotty S; Harris AD
    mSphere; 2022 Dec; 7(6):e0027922. PubMed ID: 36321826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of IgG Titers in Hemodialysis Patients and Controls Following Administration of the COVID-19 Vaccine.
    Jozpanahi M; Jafari R; Moharrer M; Mahmoudi P; Saeed SP; Dinmohammadi H
    Int Tinnitus J; 2024 Mar; 27(2):183-190. PubMed ID: 38507633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination.
    Guiomar R; Santos AJ; Melo AM; Costa I; Matos R; Rodrigues AP; Kislaya I; Silva AS; Roque C; Nunes C; Aguiar J; Graça F; Silva Graça A; Machado A
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody level dynamics until after the third dose of COVID-19 vaccination.
    Asahi N; Sakamaki I; Hida Y; Torii K; Hashimoto N; Iwasaki H; Iwano M; Kimura H
    Heliyon; 2023 Jun; 9(7):e17477. PubMed ID: 37361132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
    Scaggs Huang F
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.